FreeCE.com Catalog of Homestudy CE Programs

An Update on HIV Therapy: Protease Inhibitors for Treatment Experienced Patients

Wed, 08 Jul 2009 00:00:00 GMT

This program will enhance the pharmacists understanding of HIV therapy and the use of protease inhibitors for treatment experienced patients. The program includes information on pharmacologic treatments, patient counseling and a question/answer period.This program does not fulfill the FL HIV requirement.

Fast Facts in OTC PPI's

Thu, 12 Aug 2010 00:00:00 GMT

50 million Americans are estimated to have frequent heartburn, defined as symptoms occuring at least 2 days/week. Many of these sufferers experience nighttime symptoms, which are often associated with a higher rate of complications. Many heartburn sufferers see the advice of their pharmacist on how they should best relieve their symptoms, and may express concerns over the safety issues that may arise with their OTC medication. Frequent heartburn can be treated effectively over the 24 hour dosing interval with a once daily PPI given OTC. This knowledge based webinar aims to provide pointers on who is at risk of frequent heartburn, how to recognize symptoms and alarm symptoms, how to decide who is appropriate for OTC PPI treatment, and who should be recommended to see their physician, as well as discussing safety concerns. The webinar is based on a series of frequently asked questions to provide an opportunity to discuss many of key issues relating to the management of frequent heartburn and OTC PPI's.

Women, Cholesterol and Cardiovascular Disease-The Trilogy

Wed, 01 Sep 2010 00:00:00 GMT

This program will promote the need for increased awareness of the cardiovascular disease (CVD) in women. Second, this program focuses on methods for health care providers to improve cardiovascular care, and manage medications for cholesterol and other related co-morbidities. Health care providers must understand the potential of currently available treatment options and play an active role in educating patients on their strategies for cholesterol management.

Relieving Frequent Heartburn - Day through Night

Wed, 14 Jul 2010 00:00:00 GMT

50 million Americans are estimated to have frequent heartburn, defined as symptoms occurring at least 2 days / week. Many of these sufferers experience nighttime symptoms, which are often associated with a higher rate of complications. Most episodes of nighttime reflux occur during the first few hours of sleep and lead to a broken sleep pattern. This can result in daytime fatigue, affecting quality of life and work productivity. Many heartburn sufferers seek the advice of their pharmacist on how they should best relieve their symptoms. Frequent heartburn can be treated effectively over the 24 hour dosing interval with a once daily PPI given OTC. This knowledge based webinar aims to provide pointers on who is at risk of frequent heartburn, what questions to ask to diagnose heartburn and recognize nighttime symptoms, and how to decide who is appropriate for OTC PPI treatment and who should be recommended to see their physician. The webinar includes a case scenario to provide an opportunity to discuss many of the key issues relating to the management of frequent heartburn with nighttime breakthrough.

Benign Prostatic Hyperplasia (BPH) - When Bigger is Not Better

Mon, 28 Nov 2011 00:00:00 GMT

To provide nurse and pharmacists with an understanding of benign prostatic hyperplasia (BPH).

A Question of Ethics: Treating Pain for the Dying Patient

Wed, 15 Jun 2011 00:00:00 GMT

This knowledge-based program will assist pharmacists in understanding facets of the pain felt by patients who are dying and the ethics involved with alleviating the pain during this process. It will also enhance their knowledge of available options for those patients in this situation. The program includes information on pharmacologic treatments and patient counseling.

Help for the Pain - The Pharmacist's Role in Treating Fibromyalgia

Thu, 21 Jan 2010 00:00:00 GMT

Pharmacists can play a key role in alleviating the shortcomings and the misunderstanding about fibromyalgia. They can provide valuable counseling on topics such as lifestyle modifications and treatment options for fibromyalgia. Simple changes can often lead to considerable symptom improvement. Once fibromyalgia has been diagnosed, the pharmacist can provide counseling about managing comorbidities, drug contraindications, and general safety issues.

Understanding and Treating Chronic Pain-Does Gender Matter?

Mon, 01 Nov 2010 00:00:00 GMT

Healthcare professionals, including pharmacists, often are barriers to improving the pain management of their patients primarily because of their lack of pain-management education and their unfounded fears and biases. Optimizing pain relief is crucial to helping a patient regain control of his or her life. Because pharmacotherapy plays a prominent role in treating chronic pain, it is also a perfect opportunity for the pharmacist to be involved. This program will satisfy the education need by creating a program for pharmacists that will enhance their understanding of chronic pain, the gender gap, pharmacotherapy, counseling points, and information needed to work with the patient to reduce pain and improve quality of life.

Current Management of Gestational Diabetes Mellitus

Fri, 20 May 2011 00:00:00 GMT

To provide participants with an understanding current management methods and strategies for gestational diabtetes mellitus.

The Pathophysiology and Pharmaceutical Treatment of Atherosclerosis

Thu, 03 Jan 2013 00:00:00 GMT

To give participants an overview of the pathophysiology and pharmaceutical treatments of atherosclerosis.

Inside the Unknown World of Autism

Thu, 16 Dec 2010 00:00:00 GMT

Currently, one in 150 live births leads to a child with a condition that is a part of the autistic spectrum disorders (ASD). While nonpharmacologic therapy is imporant for these patients, there are a number of pharmacotherapy options for the treatment of symptoms of ASD. This presentation will focus on the facts, the common myths, and the pharmacologic options for ASD.

Treatment Options for Pneumonia Across the Age Spectrum

Tue, 20 Sep 2011 00:00:00 GMT

To provide participants with an understanding of pneumonia in a variety of age groups as well as the risks each of those groups suffer.

The Mind is Willing, but the Body is Weak: Managing Chronic Pain in the Baby Boom Generation

Sun, 01 May 2011 00:00:00 GMT

This interactive, knowledge-based program will assist pharmacists in understanding facets of chronic pain experienced by the aging and the benefits of alleviating the pain as their bodies continue to change. It will also enhance their knowledge of available treatment options for those patients under these conditions. The program includes information on pharmacologic treatments and patient counseling.

The Pathophysiology and Pharmaceutical Treatment of Gout

Fri, 16 Dec 2011 00:00:00 GMT

To provide pharmacists and nurses with an understanding of the pathophysiology and pharmaceutical treatment of gout.

Diabetic Peripheral Neuropathy - A Painful Complication

Wed, 15 Dec 2010 00:00:00 GMT

Neuropathy is a common microvascular complication affecting nearly 50% of patients with diabetes. Complications from diabetic neuropathy account for 50% to 75% of nontraumatic amputations. The total annual cost of diabetic neuropathy and its complications in the United States is estimated to be between $4.6 and $13.7 billion. Pharmacists in all healthcare settings play an important role in the prevention and treatment of diabetic neuropathy.

Understanding and Managing Epilepsy

Tue, 21 Jul 2009 00:00:00 GMT

Epilepsy is a neurological disorder in which clusters of nerve cells in the brain sometimes signal abnormally. This disorder affects about 2.7 million Americans, and results in an estimated annual cost of $15.5 billion in medical costs and lost or reduced earnings and production. People of all ages are affected, but particularly the very young and the elderly. For epilepsy, understanding the disorder and behaviors associated with it is imperative. The pharmacological approach to this disorder is specific and may require special attention. This program is designed to assist pharmacists in reviewing the facets of the condition of epilepsy, as well as the benefits of controlling episodes with medications. Their knowledge of available options for epileptic patients will be enhanced. The program includes information on pharmacologic treatments, drug interactions, patient counseling, and a question/answer period.

Women Survivors: Chronic Pain Continues after Breast Cancer

Tue, 01 Jun 2010 00:00:00 GMT

This knowledge based program will assist pharmacists, technicians, and nurses in understanding facets of the chronic pain felt by women who have survived breast cancer, and the benefits of alleviating the pain during this process. It will also enhance their knowledge of available options for those patients under these conditions. The program includes information on pharmacologic treatments, patient counseling.

Classes of Medication for Depression and Key Counseling Points

Tue, 18 Oct 2011 00:00:00 GMT

The role of pharmacists in the treatment of depression can be a key role. Pharmacists must understand not only the etiology of depression, but also the available treatment options. These treatment options include: standard doses, possible side effects, off-label uses of medications, medical emergencies, and educating patients and their families about common medications and treatments.

Medication Errors, Public Safety and Protecting Your License

Wed, 15 Sep 2010 00:00:00 GMT

According to the Food and Drug Administration, medication errors cause at least one death every day and injure approximately 1.3 million people annually in the United States. Medication error morbidity and mortality costs are estimated to run $77 billion dollars per year. Patient safety is a major public health concern. PharmCon recognizes the importance of this issue. This knowledge-based program emphasizes and promotes public safety, continuous monitoring for accuracy in dispensing, reliability in the transmission of prescription and medication orders, and continuous review and upgrade of pharmacy operating systems.

OTC-ORAL: A Review of Over-the-Counter Oral Dosage Forms

Thu, 27 Jan 2011 00:00:00 GMT

This program will provide pharmacists, technicians, and nurses with an overview of OTC medications and identify techniques for OTC counseling and patient consultation. The goal of this program is to educate fellow healthcare professionals regarding the selection process of appropriate over-the-counter medications.

Managing Postprandial Glucose

Tue, 02 Feb 2010 00:00:00 GMT

Pharmacists are often the medical professional that patients reach out to for the latest in drug information. With all the new products available for diabetes, it is very difficult for the pharmacist to keep up with the latest advances in medication. In addition, the newer medications require more explanation than in the past. This continuing education course gives the pharmacist a solid knowledge base to enlighten the patients on these new therapies with an emphasis on methods to help the patient control postprandial glucose.

I've Got a Secret: Indentifying and Treating Urinary Incontinence in the Elderly

Thu, 01 Sep 2011 00:00:00 GMT

I’ve got a secret …Or keeping her secret should not be Maxine’s first and foremost concern when out shopping with the grand kids. When she visits the pharmacy in search of adult incontinence briefs, are you ready to help her with her bladder control issues? As frontline providers, pharmacists can help patients cope with this debilitating and embarrassing disorder. This program will educate pharmacists on barriers to diagnosis and treatment of urinary incontinence, treatment options and strategies to engage and to counsel patients about urinary incontinence.

Risks Associated with Testosterone Replacement Therapy: A Safety Review

Thu, 16 Dec 2010 00:00:00 GMT

This program is designed to assist pharmacists, nurses, and nurse practitioners to better understand the potential risks associated with testosterone replacement therapy. Health care professionals will be updated on available testosterone treatment therapies. The program includes information on pharmacologic treatments, drug interactions, patient counseling, and safety risks.

Medication Error Reduction Perspectives From Two States With Legal Case Analysis -LAW-

Mon, 16 Feb 2009 00:00:00 GMT

The pharmacy profession has had no choice but to respond to public concern about the errors committed by pharmacists. Although errors are normal and are present in every profession, pharmacy has been the subject of intense scrutiny for the past decade, and the need to open up under scrutiny has challenged pharmacists to put their best feet forward. There are certainly many reasons for pharmacy error that exist well outside the individuals who practice pharmacy and the places where they practice. But laying the blame on third party programs that provide woefully inadequate reimbursement, prescribers who communicate unclearly, or patients who refuse to accept responsibility is beside the point. Pharmacists must themselves step up to the plate and offer solutions that are within their control.

As a profession, pharmacists speak from a regulatory perspective through their boards of pharmacy. In most states the regulatory agency responsible for pharmacists does more than licensing; it establishes standards for pharmacist practice and for the maintenance of a pharmacy practice site. It is through this self-governing regulatory agency that pharmacists can best show the public that patient care is the most critical concern to the profession, and that the standard is pharmacy is not just to protect public health but to promote public health.

In this program, the responses of two states to the problem of pharmacy error are highlighted. The two states are Florida and Washington. But these two case studies could be stories from any state, because there is no reason to think that pharmacy differs greatly in any of the 50 states. What is important about the experiences in these states is not that they are perfect. They do not necessarily serve as a model for all other states to follow. But they do provide useful information about pharmacy error, and they also describe how pharmacists can collectively learn from errors of the past and improve practices in the future. Get the best information from this knowledge based article.

Modifying the Progression of Atherosclerosis

Fri, 01 Apr 2011 00:00:00 GMT

This program will review recent developments in the understanding of how statins modify the progression of atherosclerosis, describe the clinical benefits and limitations of statin therapy and outline the clinical evidence that has shaped today’s concepts of cholesterol management. The pharmacist must understand the potential of currently available therapies (along with their probable results and possible side effects) and play an active role in educating patients on their strategies for modifying the progression of atherosclerosis.

Living with Multiple Sclerosis

Fri, 08 Oct 2010 00:00:00 GMT

This program will assist pharmacists in understanding facets of the debilitating effects MS has on its patients,and the challenges of treating and counseling its victims. It will also enhance their knowledge of available options for those patients suffering from these conditions. The program includes information on pharmacologic treatments and patient counseling.

Florida Approved - HIV /AIDS Treatment Update

Fri, 15 Aug 2008 00:00:00 GMT

AIDS (acquired immunodeficiency syndrome) was first reported in the United States in 1981 and has since become a major worldwide epidemic. AIDS causes HIV (human immunodeficiency virus). By killing or damaging cells of the body's immune system, HIV progressively destroys the body's ability to fight infections and certain cancers. People diagnosed with AIDS may contract life-threatening diseases called opportunistic infections, which are caused by microbes such as viruses or bacteria that usually do not make healthy people sick. The CDC estimates that as many as 950,000 Americans may be infected with HIV, one-quarter of whom are unaware of their infection.

The Role of the Pharmacist as 'Gate Keeper' to the Appropriate Use of OTC PPI Therapy in Frequent Heartburn

Thu, 01 Jul 2010 00:00:00 GMT

50 million Americans are estimated to have frequent heartburn, defined as symptoms occurring at least 2 days a week. Probably the best way to manage these patients is with a proton pump inhibitor, which can be purchased OTC. Often heartburn sufferers seek the advice of a pharmacist on how they should best relieve their symptoms. This knowledge-based webinar aims to provide helpful pointers on who is at risk of frequent heartburn, what questions to ask to diagnose the condition, and how to decide who is appropriate for OTC PPI treatment and who should be recommended to see their physician. To help bring this into a real work perspective, there is a case scenario built into the presentation which provides the opportunity to discuss many of the key issues relating to the management of this common condition.

Using Behavioral Approaches to Bladder Care and Making Anticholinergics Work More Effectively

Fri, 23 Dec 2011 00:00:00 GMT

To provide nurses and pharmacists with an understanding the use of behavioral control to regulate bladder and methods in making anticholinergics more effective.

Treating Chronic Pain While Preventing Abuse and Diversion of Prescription Opioids

Thu, 08 Sep 2011 00:00:00 GMT

Healthcare providers and pharmacists in particular must ensure that they have appropriate control measures in place to minimize abuse and diversion of prescription drugs. Dispensing procedures without control and professional caution are an invitation to the drug abuser. Proper controls can be accomplished by following common sense, sound professional practice, and proper dispensing procedures. In addition, pharmacy staff should have knowledge of these safeguards, as it will help prevent and protect the pharmacy from becoming a source of diversion. This program will provide pharmacists with an overview of opioid pain medication and identify the signs of abuse and diversion that can occur with patients, family or friends. The program will emphasize the role of the pharmacist in intervening and educating patients to prevent abuse and diversion while optimizing pain management.

Understanding and Treating Acute Coronary Syndrome

Tue, 15 Feb 2011 00:00:00 GMT

Pharmacists can make a difference in the management and treatment of acute coronary syndrome. This program will educate healthcare providers on ACS treatment guidelines, provide an update on pharmacotherapy, and the challenges associated with ACS treatment so they can more comfortably respond to patients and providers in their role as pharmacist.

Seeing the Truth About Childhood Schizophrenia

Wed, 18 Nov 2009 00:00:00 GMT

This program is designed to assist healthcare professionals in reviewing the facets of childhood schizophrenia, as well as the benefits of managing this disorder with medications. Their knowledge of available treatment options for children with schizophrenia will be enhanced. The program includes information on pharmacologic treatments, drug interactions, and patient counseling.

The Pharmacist's Role in Treating Bipolar Disorder

Wed, 08 Jul 2009 00:00:00 GMT

Pharmacists can play a pro-active role in the treatment of bipolar disorder and the adherence problems associated with the illness. Pharmacists must understand the underlying condition, potential of currently available treatment options (along with their probable results and possible side effects) and understand the need to educate patients and family members on drug treatment strategies and the long-term medication and adherence problems commonly encountered with bipolar patients.

Conquering Major Depressive Disorder in Rural Communities - The Pharmacist's Role

Wed, 08 Jul 2009 00:00:00 GMT

Major Depressive Disorder is a condition characterized by one or more Major Depressive Episodes without a history of manic, mixed, or hypomanic episodes. MDD is a major mental health condition, with statistics proving that completed suicide occurs in up to 15% of individuals with severe cases! Major Depressive Episode can be conquered! With correct intervention, up to two-thirds of these cases may completely recover. This program is designed to assist pharmacists review the facets of Major Depressive Disorder (MDD), especially in rural areas of the United States, as well as the benefits of managing this disorder with medications. Their knowledge of available treatment options for victims of MDD will be enhanced. The program includes information on pharmacologic treatments, drug interactions, patient counseling, and a question/ answer period.

Vitamin D Benefits for Bones and Beyond: New Dosage Recommendations and Potential Uses

Tue, 28 Jun 2011 00:00:00 GMT

To provide participants with an understanding of new dosing and uses of Vitamin D supplements for bone health and related fields.

Treating Breakthrough Cancer Pain - What Pharmacists Need to Know

Fri, 01 Apr 2011 00:00:00 GMT

Pain is one of the most common, yet misunderstood and feared symptoms of cancer. Breakthrough cancer pain when left untreated significantly impacts quality of life. The treatments available for breakthrough cancer pain require health care providers and pharmacists in particular to pay strict attention to REMS process set up by pharmaceutical companies. This program will enhance the pharmacists' understanding of breakthrough cancer pain, provide pharmacists with an overview of the pain medications available for opioid tolerant cancer patients with breakthrough cancer pain, describe the REMS processes, delineate strategies, and mitigate the risk of abuse and misuse of these pain medications.

Emily's Act: An Impact on Public Safety and Medication Errors -LAW-

Fri, 15 Oct 2010 00:00:00 GMT

Emily Jerry was nearly ready to go home from a Cleveland hospital. The grapefruit-size tumor in her abdomen seemed gone, and the 2-year-old was getting one last round of chemotherapy just to make sure. Instead, a medication error killed her. A pharmacy technician mixed Emily's chemotherapy drug with a saline solution 26 times above normal. The pharmacist-on-duty was eventually convicted of involuntary manslaughter. Join us in reviewing the facts of this case that has nationwide impact and is the cause of significant changes in the pharmacy profession. Attention Florida Pharmacists & Technicians: This one hour presentation does not satisfy the medication errors requirement for the State of Florida.

Treating Parkinson's Disease: A Pharmacist's Update

Fri, 19 Jun 2009 00:00:00 GMT

The goal of this program is to supply program participants with up-to-date information on the epidemiology, etiology, and pathophysiology of Parkinson's disease. Participants will also gain knowledge on the symptoms and comorbidities of Parkinson's disease and currently available treatment options.

Medication Treatment Alternatives for Autism Spectrum Disorder

Thu, 25 Aug 2011 00:00:00 GMT

This knowledge based activity will provide an extensive overview of the pharmacological therapy of the associated behaviors of the autism spectrum disorders. The program will provide a brief review of information related to the pervasive development disorders. The focus will then shift to the analysis of available literature for the pharmacotherapy of the associated symptoms.

The Use of Herbal and Dietary Supplements in the Treatment of Herpes Simplex Virus Types 1 & 2

Thu, 14 Jul 2011 00:00:00 GMT

To provide nurses and pharmacists with an understanding of treating the herpes simplex virus types 1 and 2 with herbal and dietary supplements.

COPD with a Focus on the Epidemiology, Pathophysiology, and Treatment Options

Mon, 22 Aug 2011 00:00:00 GMT

To provide nurses and pharmacists with an understanding of COPD treatment options as well as its epidemiology and pathophysiology.

Opioid and Opioid Rotation - What Pharmacists Need to Know

Sat, 01 Oct 2011 00:00:00 GMT

Because of their knowledge of opioid medications, pharmacists can provide valuable information on the most appropriate opioid for pain management and perform a comprehensive review of past and current pharmacologic interventions. There are so many reasons why switching from one opioid analgesic to another may be necessary and helpful, yet safely doing so appears to involve as much clinical art as science. This can make healthcare providers and their patients justifiably nervous, and may be a prime reason why opioids are not prescribed appropriately. What can practitioners do? This knowledge based activity will use case studies and examples to educate healthcare providers on opioid rotation and dose conversions.

Detection of Hypogonadism and Applying Testosterone Replacement Therapy

Tue, 17 Nov 2009 00:00:00 GMT

This program is designed to assist pharmacists, nurses, and nurse practitioners to better understand how to properly diagnose a patient suffering from hypogonadism. These health care professionals will also be updated on available testosterone treatment therapies. The program includes information on pharmacologic treatments, drug interactions, and patient counseling.

A Review of Pathophysiology and Medicinal Treatment Options of Rheumatoid Arthritis

Thu, 28 Apr 2011 00:00:00 GMT

To provide participants with an understanding of pathophysiological and medicinal treatment options for rheumatoid arthritis.

Diabetes and Dyslipidemia - What About Statins

Wed, 17 Aug 2011 00:00:00 GMT

To provide nurses and pharmacists with an understanding of diabetes and dyslipidemia treatment with statins in regards to safety and effectiveness.

A Clinical Update in Diabetes Management

Fri, 01 Oct 2010 00:00:00 GMT

Approximately 24 million Americans have diabetes, and an additional 50 million or more people have "pre-diabetes". Due to the high prevalence of diabetes mellitus, it's not surprising that therapeutic advances in the management of diabetes are a healthcare priority in the United States. Participants in this presentation will learn about new drugs approved for the management of diabetes (e.g., saxagliptin, liraglutide), and news about medications currently available to treat diabetes (e.g., new developments with exenatide, cancer risk with insulin, labeling changes with insulin secretogogues, and the thiazolidinedione controversy). Medications in the pipeline for the management of diabetes will also be discussed. Participants will also learn about updated information concerning therapeutic goal setting for patients with diabetes, and how recent research has influenced this important part of practice. Last, participants will review updated medical management guidelines for Type 2 diabetes mellitus from the American Diabetes Association and other groups.

HIV Diagnosis & Treatment - A 25 Year Journey - FL Approved -

Thu, 29 Sep 2011 00:00:00 GMT

AIDS has killed more than 25 million people since 1981. That’s about half as many deaths as in World War II. And it's not over. 1.1 million Americans are among the 33 million people now living with HIV, the virus that causes AIDS. This knowledge based program will educate pharmacists on HIV treatment principles and current guidelines for use of antiretroviral therapy so they can more comfortably respond to HIV patients and providers in their role. The program includes information on pharmacologic treatments, patient counseling, and a question/answer period.

This program is approved for by the Florida Board of Pharmacy to meet HIV/AIDS requirements in the state of Florida.

A Prescription for Pharmacist Burnout

Wed, 03 Feb 2010 00:00:00 GMT

At some point in your pharmacy career, you will experience burnout. Regardless of how much you like your job, there will come a time when you just don't feel like doing it anymore. If you could choose between being sick enough to stay home (and not just lying about being sick) and going to work, you would actually choose to be sick. It would be far less aversive than facing your boss, your co-workers, your patients, and your desk. This program identifies the causes of burnout and helps you identifies ways to avoid burnout and enjoy your job and life to the full extent.

Current Prevention and Treatment Strategies for Influenza

Fri, 05 Aug 2011 00:00:00 GMT

To provide pharmacists, pharmacy technicians, and nurses with an understanding of current prevention and treatment strategies for influenza.

Chronic Pain Patients and Drug Diversion: Protecting Your Pharmacy Practice

Wed, 08 Jul 2009 00:00:00 GMT

The purpose of this activity is to provide participants with a comprehensive strategy to deal with the problems and opportunities associated with the dispensing of opioids to legitimate chronic pain patients. Emphasis is on methods to differentiate the legitimate chronic pain patient from those patients who seek to abuse and divert CDS medications.

Understanding and Treating Post-Herpetic Neuralgia

Wed, 08 Jul 2009 00:00:00 GMT

This program will focus on the challenges faced by healthcare professionals in diagnosing and treating patients with PHN, and will enhance the participant's knowledge of PHN, counseling points, and information needed to work with the patient to reduce pain and improve quality of life.

Asthma with a Focus on the Epidemiology, Pathophysiology, and Treatment Options

Mon, 22 Aug 2011 00:00:00 GMT

To provide nurses and pharmacists with an understanding of asthma treatment options as well as its epidemiology and pathophysiology.

A Pharmacist's Role in the Management of Prescription Drug Abuse

Thu, 01 Dec 2011 00:00:00 GMT

To provide nurses and pharmacists
with an understanding of a pharmacist’s role in the management of prescription
drug abuse.

Palliative Care - Treatment at the End of Life

Fri, 01 Oct 2010 00:00:00 GMT

This program will assist pharmacists, pharmacy technicians, and nurses in understanding the facets of the palliative pain felt by patients who are dying and the benefits of alleviating the pain during this process. It will also enhance their knowledge of the available options for those patients in this situation. The program includes information on the pharmacological treatments and patient counseling.

The Reality of Adolescent Depression

Tue, 15 Feb 2011 00:00:00 GMT

This program promotes the need for increased awareness of depression in adolescents. About 20 percent of teens will experience teen depression before they reach adulthood. Less than 33 percent of teens with depression get help, yet 80 percent of teens with depression can be successfully treated if they seek help from a doctor or therapist, and many local health clinics offer free or discounted treatment for teens with depression. This program is designed to assist pharmacists in understanding Major Depressive Disorder (MDD), especially in adolescents, as well as the benefits of managing this disorder with medications. The program includes information on pharmacologic treatments, drug interactions, and patient counseling.

Medication Errors and Public Safety: Tragic Consequences When the System Breaks Down -FL APPROVED/LAW

Mon, 16 May 2011 00:00:00 GMT

To provide pharmacists with an understanding of pharmacy dispensing errors, including causes, prevention, and the legal issues resulting from these errors.

This is approved for FL Medication Errors Credit

The Prophylaxis and Management of Hemophilia in Adults and Pediatrics

Fri, 01 Apr 2011 00:00:00 GMT

This knowledge-based, interactive program will assist pharmacists in understanding facets of hemophilila, and the challenges of treating and counseling its vicitms. It will also enhance their knowledge of available options for those patients under these conditions. The program includes information on pharmacologic treatments and patient counseling.

Chronic Pain in the Golden Years - Aging Gracefully or Suffering in Silence

Sat, 15 Oct 2011 00:00:00 GMT

Seniors are particularly vunerable to chronic pain. As we age, our bodies go through intense changes. Optimizing pain relief is crucial to helping an aging patient regain or maintain control of his or her life. Because pharmacotherapy plays a prominent role in treating chronic pain, it is also a perfect opportunity for the pharmacist to be involved. This program will satisfy the education need by creating a program for pharmacists that will enhance their understanding of chronic pain, the challenges associated with treating an aging population, pharmacotherapy, counseling points, and information needed to work with the patient to reduce pain and improve quality of life.

Women Beware - The Threat of COPD

Fri, 13 Nov 2009 00:00:00 GMT

Women have made a good deal of welcome progress in the last several decades, but at least one advance is unwanted: chronic obstructive pulmonary disease (COPD) is on the rise in women in prevalence, morbidity and mortality. By 2000, the number of women dying from COPD surpassed the number of men. But the rising number of cases in women has not been matched by medical understanding of the disease's apparent gender-bias. This program will focus on the pharmacist's role in identifying patients with COPD (women in particular), reducing the risk factors for developing COPD (such as smoking cessation), and managing the disease.

When Pain Relief Leads to Pain Medication Abuse-Pharmacists Intervene

Sat, 01 Jan 2011 00:00:00 GMT

This knowledge-based program will assist pharmacists in understanding the facets of pain felt by patients, and the justifications patients may give for abusing pain medications. The program is designed to enhance pharmacists' knowledge of available information for these patients, and includes information on elements of pharmacologic treatments and patient counseling.

Schizophrenia and Weight Gain - Strategies to Improve Adherence

Thu, 01 Dec 2011 00:00:00 GMT

Independent of medication, schizophrenia always has been associated with weight gain. Up to 50% of patients taking antipsychotics gain weight. Additionally, weight gain is associated with non adherence, relapse and decreased quality of life. This program will give pharmacists an understanding of the underlying conditions, potential of currently available treatment options (along with their probable results and possible side effects) and the need to educate patients and family members on drug treatment strategies and the long-term medication adherence problems commonly encountered with schizophrenia.

Strategies to Improve Communications Between Pharmacy Staff and Patients

Wed, 10 Dec 2008 00:00:00 GMT

Health literacy is a complex issue which is made up of many areas including the ability to understand instructions on prescription drug bottles, appointment slips, medical education brochures, doctor's directions and consent forms, and the ability to negotiate complex health care systems. Requirements include reading, listening, analytical and decision-making skills, and the ability to apply these skills to health situations. The U.S. Department of Health and Human Services has even included improved consumer health literacy as Objective 11-2, and identified health literacy as an important component of health communication, medical product safety, and oral health in the report Healthy People 2010. In many cases, your patients depend on you! This program will help you to understand the effects of health literacy and how you can communicate with your patients, eliminating many fears and insecurities associated with healthcare. Implementing these techniques will contribute to improving overall quality of healthcare and reducing economic costs related to low health literacy. This program will define health literacy as well as review techniques to improve communication with low-literacy patients. You will become a better resource for your patients, allowing them to take a more active role in their own healthcare decisions.

Wake Up -- Understanding and Treating Excessive Sleepiness

Mon, 11 Jan 2010 00:00:00 GMT

This program is designed to educate pharmacists on the treatments for excessive sleepiness and offer them counseling points to communicate effectively with excessive sleepiness patients and providers in their role as a pharmacist.

Prostate Cancer: Managing Associated Pain

Thu, 15 Jul 2010 00:00:00 GMT

This knowledge-based program will assist pharmacists and nurses in understanding facets of the painful episodes men may experience during bone metastasis of prostate cancer, and the benefits of alleviating the pain during this process. It will also enhance their knowledge of available options for those patients under these conditions. The program includes information on pharmacologic treatments and patient counseling.

Cardiovascular Disease in Rheumatoid Arthritis

Wed, 24 Aug 2011 00:00:00 GMT

To provide nurse and pharmacists with an understanding cardiovascular disease and effects on rheumatoid arthritis.

Managing Warfarin Therapy in Various Pharmacy Settings

Thu, 07 Jan 2010 00:00:00 GMT

Despite warfarin's efficacy as an oral anticoagulant, this agent continues to exude prominence within medication error reports, inappropriate health care utilization, and adverse consequences. In summation, this article offers an overview for pharmacist operation in accordance with novel standards and regulations to enhance the delivery of anticoagulation. Although pilot studies have been conducted regarding community-based anticoagulation management, to date, this foundation has not been reconciled in the absence of definitive models, pharmacoeconomic analyses, and direct evidence-based outcomes of pharmacist intervention. Pharmacists need to play an increasingly active role to minimize healthcare expenditures and preserve older adult's quality of life

Reducing the Risk of Stroke in Patients with Atrial Fibrillation

Mon, 01 Aug 2011 00:00:00 GMT

Approximately 75,000 strokes occur each year in the United States in patients with atrial fibrillation. Current guidelines recommend oral anticoagulation for high-risk patients with atrial fibrillation, but the inherent limitations of these agents lead to substantial underuse. This state of affairs has stimulated the development of new agents with improved benefit-risk profiles, which appear to be offer a wider therapeutic margin and low potential for drug interactions, allowing more convenient dosing without anticoagulation monitoring. Pharmacists must understand the underlying condition, possible comorbid conditions, potential of currently available treatment options (along with their probable results and possible side effects) and play an active role in educating patients on their drug treatment strategies and lifestyle changes necessary to reduce the risk of stroke in atrial fibrillation.

Diabetes Potpourri 2010: A Summary of Several Current Issues In the Management of Diabetes

Thu, 17 Mar 2011 00:00:00 GMT

This program will provide a literature-based review of several current issues facing the management of diabetes mellitus. Based on the results of recent clinical trials, some significant changes to the management of diabetes mellitus either have or appear likely to occur soon. It is important that pharmacists are attuned to this information and apprised of these changes so they can work with a patient's healthcare team to optimize care.

The Pathophysiology and Pharmaceutical Treatment of Hypertension

Fri, 30 Dec 2011 00:00:00 GMT

After the completion of this monograph, the reader should understand the prevalence and incidence of hypertension, its pathophysiology, primary symptoms and main risk factors, and be able to identify the most commonly used pharmaceuticals and their potential side effects.

Three Generations: The Past, Present, and Future of Transdermal Drug Delivery Systems

Mon, 16 May 2011 00:00:00 GMT

To provide pharmacists with an understanding of pharmacy dispensing errors, including causes, prevention, and the legal issues resulting from these errors.

Osteoporosis Update: Adding New Tools and Treatments to Disease Management

Tue, 22 Nov 2011 00:00:00 GMT

To give participants an overview of new tools and treatments in the disease state management of osteoporosis, specifically in the form of an update to existing information.

Managing Epilepsy - Pharmacists Help

Wed, 08 Jul 2009 00:00:00 GMT

This program will review the theoretical causes of epilepsy as well as the detrimental affects that this disorder may have on its victim's lives, incorporating information on its prevalence. Participates will also hear about therapeutic agents used in the treatment of epilepsy and should be able to state an agent's dosage schedule, mechanism of action, and side effects following completion of the program.

Diabetes Double Jeopardy - What do Minorities and Senior Citizens Have in Common

Fri, 01 Oct 2010 00:00:00 GMT

This program promotes the need for increased awareness of diabetes in minorities and the elderly. The program will focus on the pharmacist's role in identifying patients with diabetes (minorities and the elderly in particular), reducing the risk factors for developing diabetes through lifestyle changes, and managing the disease. Pharmacists are often the medical professional that patients reach out to for the latest in drug information. With all the new products available for diabetes, it is very difficult for the pharmacist to keep up with the latest advances in medication. In addition, the newer medications require more explanation than in the past. This continuing education course gives the pharmacist a solid knowledge base to enlighten the patients on these new therapies with an emphasis on methods to help the patient control postprandial glucose, provide counseling about managing comorbidities, drug contraindications, and general safety issues.

Types of Diarrhea and Management Strategies

Fri, 03 Jun 2011 00:00:00 GMT

To provide nurses, pharmacists, and pharmacy technicians with an understanding of diarrhea types and management strategies.

Head Lice Treatment Options Today

Tue, 28 Jun 2011 00:00:00 GMT

To provide nurses, pharmacists, and pharmacy technicians with an understanding of head lice treatment options today.

New Treatment Considerations for Type 2 Diabetes Mellitus

Fri, 16 Dec 2011 00:00:00 GMT

To provide nurses and pharmacists with an understanding of new treatment considerations for type 2 diabetes mellitus

Urinary Incontinence - An Epidemic?

Tue, 09 Aug 2011 00:00:00 GMT

To provide pharmacists and nurses with an understanding of urinary incontinence and its prevalence so as to be better prepared in their practice.

Intermittent Androgen Deprivation Therapy for Treatment of Prostate Cancer – What are the Benefits?

Fri, 05 Aug 2011 00:00:00 GMT

To provide Pharmacists and Nurses with an understanding of Androgen Therapy and its relation to Prostate Cancer treatment.

HIV/AIDS Treatment - Pharmacists Can Make a Difference

Sat, 01 Jan 2011 00:00:00 GMT

Pharmacists can make a difference in the management and treatment of HIV/AIDS. However, many pharmacists find themselves uncomfortable with their level of knowledge in the area of HIV either because they did not receive any HIV training in their formal education or simply because of the rapid on-going advancements in this therapeutic area. This program will educate pharmacists on HIV treatment principles, provide an update on pharmacotherapy, and the challenges associated with HIV treatment so they can more comfortably respond to HIV patients and providers in their role as pharmacist. (NOT APPROVED by the Florida BOP)

Understanding Diabetes and Insulin Delivery Systems

Thu, 23 Jul 2009 00:00:00 GMT

This program will educate pharmacists on currently available insulin delivery options and information needed to counsel and treat patients while also improving medication adherence.

Treating Chronic Pain - Opioid Analgesics

Mon, 03 Oct 2011 00:00:00 GMT

The June 29, 2011 report titled: Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research from the Institute of Medicine offers many insights into pain management. Pain is a major driver for visits to physicians, a major reason for taking medications, a major cause of disability, and a key factor in quality of life and productivity. Given the burden of pain in human lives, dollars, and social consequences, relieving pain should be a national priority. This activity will focus on the current state of chronic pain management, the continued need for opioid analgesics, and how these issues speak to the pharmacist working in the community setting.

After 30 Years - Living with HIV

Wed, 01 Jun 2011 00:00:00 GMT

Many pharmacists find themselves uncomfortable with their level of knowledge in the area of HIV either because they did not receive any HIV training in their formal education or simply because of the rapid on-going advancements in this therapeutic area. This program will educate pharmacists on HIV treatment principles, provide an update on combination therapy, and the challenges associated with HIV treatment so they can more comfortably respond to HIV patients and providers in their role as a pharmacist. This program is NOT approved for Florida Pharmacists and Pharmacy Technicians.

Autoimmune Disease Control: New Treatments for Old Problems

Thu, 01 Sep 2011 00:00:00 GMT

To provide participants with an understanding of autoimmune disease control and new methods being employed.

Liver Disorders: Diagnosis, Treatment, and Acetaminophen Associated Hepatotoxicity

Fri, 16 Sep 2011 00:00:00 GMT

To provide participants with an understanding of liver disorders, their diagnosis, treatment options, and acetaminophen associated hepatotoxicity.

Old Wine in New Bottles: A Review of Current ADHD Treatments

Mon, 07 Nov 2011 00:00:00 GMT

Many of the pharmaceutical options for treating Attention Deficit Hyperactivity Disorder have been around for decades. Newer versions of these same medicines are coming to market seemingly every year. However, some truly newer medicines, especially adjuvant medicines, have been introduced recently. A review of the older therapeutic options and a summary of newer therapies can help pharmacists make sense of the expanding pharmacopoeia of ADHD treatment.

The Role of Medication Reconciliation in Ensuring Patient Safety

Thu, 14 Jul 2011 00:00:00 GMT

To provide nurses and pharmacists with an understanding of the role of medication reconciliation and how it relates to improved patient safety strategies.

ADHD: A Life Script from Conception to Adulthood

Fri, 20 Nov 2009 00:00:00 GMT

Pharmacists have consistent contact with patients over a long period of time, making them an excellent and accessible resource for information on ADHD. Moreover, pharmacists are trusted healthcare providers who interact with a large, diverse patient population. One-on-one, patient-to-pharmacist interaction is routine, and advice can often be obtained without direct or additional cost to the patient. Pharmacist and patient relationships are often much more conducive to conversation and have greater opportunities for discussion in comparison to a busy physician's office. Pharmacists can play a key role in counseling ADHD sufferers.

It's all Greek to Me-Translating the Benefits of Lipid Lowering Therapy to your Patients

Thu, 17 Mar 2011 00:00:00 GMT

It is estimated that 50% of patients who start on cholesterol lowering medications discontinue them within 6 months! This program will give you practical information on how to translate the benefits and the risks of cholesterol lowering interventions (nonpharmacologic and pharmacologic) to patients to improve adherence and persistence. Specific ways pharmacists can improve the treatment of lipid disorders will be discussed.

Attacking the Flu Bug – The Pharmacist’s Pro-Active Role in Preventing and Treating Influenza

Thu, 23 Jul 2009 00:00:00 GMT

Pharmacists can play a pro-active role in the treatment of influenza and must understand the various delivery options. This program for pharmacists will enhance their knowledge about the flu and currently available vaccine delivery options and information needed to educate and treat patients.

Understanding and Treating Hemophilia - What Pharmacists Need to Know

Thu, 15 Dec 2011 00:00:00 GMT

Pharmacists can play a pro-active role in the treatment of hemophilia, but must understand the disease and the latest advances in pharmacotherapy. Pharmacists are often the medical professional that patients reach out to for the latest in drug information. This continuing education course gives the pharmacist a solid knowledge base to enlighten the patients on therapies with an empahsis on the need for medication adherence, counseling, drug contraindications, and general safety issues.

Taking the Mystery Out of Fibromyalgia

Thu, 01 Sep 2011 00:00:00 GMT

Fibromyalgia is a chronic, musculoskeletal, non-inflammatory pain disorder. Patients frequently suffer from sleep disturbances, headaches, anxiety, morning stiffness, and a poor sense of well-being. In many cases, it takes years to properly diagnose fibromyalgia. Pharmacists can play a key role in treating patients with fibromyalgia. They can provide valuable counseling on topics such as lifestyle modifications and treatment options for fibromyalgia. Simple changes can often lead to considerable symptom improvement. Once fibromyalgia has been diagnosed, the pharmacist can provide counseling about managing comorbidities, drug contraindications, and general safety issues.